17
Views
6
CrossRef citations to date
0
Altmetric
Symposium: Patching, Drugs, or Lasik? Amblyopia Treatment in the 21st Century

Current Concepts of Amblyopia: A Neuro-Ophthalmology Perspective

, D.B.O.T., C.O., C.O.M.T.
Pages 2-12 | Published online: 22 Dec 2017

References

  • Hess RF, Howell ER: The threshold contrast sensitivity function in strabismic amblyopia: Evidence for a two-type classification. Vision Res 1977; 17: 1049–1055.
  • Levi DM, Harwerth RS: Spatio-temporal interactions in anisometropic and strabismic amblyopia. Invest Ophthalmol Vis Sci 1977; 16: 90–95.
  • Hess RF, Howell ER: The luminance-dependent nature of the visual abnormality in strabismic amblyopia. Vision Res 1978; 18: 931–936.
  • Hess RF, Campbell FW, Greenhalgh T: On the nature of the neural abnormalities in human amblyopia: Neural aberrations and neural sensitivity loss. Pflügers Archives 1978; 377: 201–207.
  • Hess RF, Campbell FW, Zimmern R: Differences in the neural basis of human amblyopias: The effect of mean luminance. Vision Res 1980; 20: 295–305.
  • Flynn JT: Amblyopia revisited (Seventeenth Costenbader Lecture). J Pediatr Ophthalmol Strabismus 1991; 28: 183–201.
  • Blakemore C, Vital-Durand F: Different neural origins for blur amblyopia and strabismic amblyopia. Ophthalmic Physiol Opt 1992; 12: 83.
  • McKee SP, Schor CM, Steinman SB, Wilson BA, Koch GG, Davis SM, Hsu-Winger C, Day SH, Chan CL, Movshon JA, Flom MC, Levi DM, Flynn JT: The classification of amblyopia on the basis of visual and oculomotor performance. Trans Am Ophth Soc 1992; 90: 123–148.
  • McKee SP, Levi DM, Movshon JA: The pattern of visual deficits in amblyopia. J Vis 2003; 3: 380–405.
  • Kiorpes L McKee SP: Neural mechanisms underlying amblyopia. Curr Opin Neurobiol 1999; 9: 480–486.
  • France LW: Evidence-based guidelines for amblyogenic risk factors. Am Orthopt J 2006; 56: 7–14.
  • Graham PA: Epidemiology of strabismus. Br J Ophthalmol 1974; 58: 224–231.
  • Donahue SP, Johnson TM: Age-based refinement of referral criteria for photoscreening. Ophthalmology 2001; 108: 2309–2315.
  • Attebo K, Mitchell P, Smith W, Jolly N, Sparkes R: Prevalence and causes of amblyopia in an adult population. Ophthalmology 1998; 105: 154–159.
  • Hess RF, Field DJ, Watt RJ: The puzzle of amblyopia. In: Blakemore C, ed. Vision: Coding and Efficiency. Cambridge: Cambridge University Press; 1990. pp. 267–280.
  • Flynn JT, Schiffman J, Feuer W, Corona A: The therapy of amblyopia: An analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophth Soc 1998; 96: 431–453.
  • Metz HS: Visual deficits in amblyopia. Arch Chil Opftal 2006; 63: 79–80.
  • von Noorden GK: Classification of amblyopia. Am J Ophthalmol 1967; 63: 238–244.
  • France TD: Amblyopia update: Diagnosis and therapy. Am Orthopt J 1984; 34: 4–12.
  • Ikeda H, Wright MJ: A possible neurophysiological basis for amblyopia. Br Orthopt J 1975; 32: 2–13.
  • Daw NW: Critical periods and amblyopia. Arch Ophthalmol 1998; 116: 502–505.
  • Barrett BT, Bradley A, McGraw PV: Understanding the neural basis of amblyopia. Neuroscientist 2004; 10: 106–117. See esp. Figure 4.
  • Hoyt CS: Amblyopia: A neuro-ophthalmic view (The Fourth William F. Hoyt Lecture). J Neuroophthalmol 2005; 25: 227–231.
  • Sireteanu R, Fronius M: Naso-temporal asymmetries in human amblyopia: Consequence of long-term interocular suppression. Vision Res 1981; 21: 1055–1063.
  • Horton JC: The central visual pathways. In: Adler's Physiology of the Eye, vol. 9. Hart WM, ed. St. Louis: CV Mosby Co.; 1992. pp. 728–772.
  • Wiesel TN, Hubel DH: Single-cell responses in striate cortex of kittens deprived of vision in one eye. J Neurophysiol 1963; 26: 1003–1017.
  • Hubel DH, Wiesel TN: Comparison of the effects of unilateral and bilateral eye closure on cortical unit response in kittens. J Neurophysiol 1965; 28: 1029–1040.
  • Hubel DH, Wiesel TN. Brain and Visual Perception: The Story of a 25-Year Collaboration. New York: Oxford University Press; 2005.
  • von Noorden GK, Dowling JE, Ferguson DC: Experimental amblyopia in monkeys: I. Behavioral studies of stimulus deprivation amblyopia. Arch Ophthalmol 1970; 84: 206–214.
  • von Noorden GK, Dowling JE: Experimental amblyopia in monkeys: II. Behavioral studies of strabismic amblyopia. Arch Ophthalmol 1970; 84: 215–220.
  • von Noorden GK: Experimental amblyopia in monkeys: Further behavioral observations and clinical correlations. Invest Ophthalmol Vis Sci 1973; 12: 721–726.
  • Hess RF, Baker CL: Assessment of retinal function in severely amblyopic individuals. Vision Res 1984; 24: 1367–1376.
  • Barnes GR, Hess RF, Dumoulin SO, Achtman RL, Pike GB: The cortical deficit in humans with strabismic amblyopia. J Physiol 2001; 533: 281–297. See esp. Figures 4–6.
  • Demer JL: Positron emission tomography studies of cortical function in human amblyopia. Neurosci Biobehav Rev 1993; 17: 469–476.
  • Sengpiel F, Blakemore C: The neural basis of suppression and amblyopia in strabismus. Eye 1996; 10: 250–258.
  • Campbell FW, Hess RF, Watson PG, Banks R: Preliminary results of a physiologically-based treatment of amblyopia. Br J Ophthalmol 1978; 62: 748–755.
  • Mazow ML: What does the future hold for amblyopia therapy? (28th Richard G. Scobee Lecture). Am Orthopt J 1998; 48: 39–46.
  • Kasamatsu T: Enhancement of neuronal plasticity by activating the norepinephrine system in the brain: A remedy for amblyopia. Neurobiology 1982; 1: 49–54.
  • Campos EC, Schiavi C, Benedetti P, Bolzani R, Porciatti V: Effect of citicoline on visual acuity in amblyopia: Preliminary results. Graefes Arch Clin Exp Ophthalmol 1995; 233–307.
  • Chatzistefanou KI, Mills MD: The role of drug treatment in children with strabismus and amblyopia. Paediatr Drugs 2000; 2: 91–100.
  • Bhartiya P, Sharma P, Biswas NR, Tandon R, Khokhar SK: Levodopa-carbidopa with occlusion in older children with amblyopia. J AAPOS 2002; 6: 368–372.
  • Leguire LE, Komaromy KL, Nairus TM, Rogers GL: Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus 2002; 39: 326–330.
  • Pandey PK, Chaudhuri Z, Kumar M, Satyabala K, Sharma P: Effect of levodopa and carbidopa in human amblyopia. J Pediatr Ophthalmol Strabismus 2002; 39: 81–89.
  • Algaze A, Leguire LE, Roberts C, Ibinson JW, Lewis JR, Rogers G: The effects of L-dopa on the functional magnetic resonance imaging response of patients with amblyopia: A pilot study. J AAPOS 2005; 9: 216–223. See esp. Figures 5 and 9.
  • PPediatric Eye Disease Investigator Group: A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003; 121: 603–611.
  • PPediatric Eye Disease Investigator Group: Two-year follow-up of a six-month randomized trial of atropine versus patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005; 123: 149–157.
  • Roper-Hall G, Burde RM: Specialized techniques in amblyopia therapy. Am Orthopt J 1981; 31: 29–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.